Bessemer Group
TMCI icon

Bessemer Group’s Treace Medical Concepts TMCI Stock Holding History

Bessemer Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-190
Closed -$2K – 2633
2025
Q1 		$2K Sell
190
-15
-7% -$135 ﹤0.01% 2277
2024
Q4 		$2K Hold
205
– – ﹤0.01% 2274
2024
Q3 		$1K Buy
+205
New +$1.32K ﹤0.01% 2553

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bessemer Group's TMCI Position: Q2 2025 in Review

Bessemer Group sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 190 shares — an estimated $2K sold.

Bessemer Group first reported a position in TMCI in Q3 2024 and held it in 3 quarters. The position peaked at $2K in Q1 2025. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Bessemer Group reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Bessemer Group sold 190 Treace Medical Concepts shares in Q2 2025, an estimated $2K.
  • Bessemer Group first reported a position in Treace Medical Concepts in Q3 2024 and held it in 3 quarters.
  • Bessemer Group's Treace Medical Concepts position peaked at $2K in Q1 2025.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Bessemer Group's 13F filing for Q2 2025, filed 1 Aug 2025.